Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $113,365,653    

Indirect Value

   $155,367,900      
Total Shares   53,734,364      
Total Value   $268,733,553      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,382,743 Rapt Therapeutics, Inc. $23,479,172 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $87,503,738 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,382,743 Rapt Therapeutics, Inc. $23,479,172 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $87,503,738 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-20 4 B $13.86 $213,385 I/I 15,400 15,868,088 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-15 4 B $13.69 $221,547 I/I 16,188 15,932,163 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-24 4 B $13.37 $238,325 I/I 17,828 49,575 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-25 4 B $4.75 $242,387 I/I 51,046 51,046 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-10 4 B $13.85 $248,234 I/I 17,923 15,709,014 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,745,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-20 4 B $13.48 $256,533 I/I 19,034 48,987 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-29 4 B $13.58 $260,727 I/I 19,201 16,112,872 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-26 4 B $13.49 $272,582 I/I 20,201 51,671 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-19 4 B $13.25 $273,922 I/I 20,666 48,359 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-12 4 B $13.88 $291,765 I/I 21,014 15,915,975 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-18 4 B $3.79 $303,256 I/I 80,000 190,000 2.25 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       •       •   2020-07-21 4 OE $13.35 $320,400 D/D 24,000 44,000 0 -
TNYA Tenaya Therapeutics, Inc. Director   –       •       •   2023-01-18 4 B $2.52 $341,432 I/I 135,688 9,800,535 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-15 4 B $10.31 $342,292 I/I 33,200 16,478,179 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-26 4 B $4.85 $353,041 I/I 72,774 123,820 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-05-10 4 B $11.36 $355,283 I/I 31,265 31,818 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-16 4 B $10.26 $358,074 I/I 34,900 16,513,079 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-14 4 B $10.36 $361,564 I/I 34,900 16,444,979 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-27 4 B $4.86 $373,638 I/I 76,877 200,697 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,554,618 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-24 4 B $13.51 $392,502 I/I 29,054 16,032,859 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-26 4 B $13.59 $408,634 I/I 30,059 16,093,671 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-23 4 B $13.35 $410,535 I/I 30,760 16,003,805 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-25 4 B $13.37 $411,294 I/I 30,753 16,063,612 2.25 -
  145  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us